InMed Pharmaceuticals Inc.
INM
$2.96
$0.24378.97%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.46M | 5.63M | 6.61M | 7.64M | 9.58M |
Total Receivables | 262.60K | 284.70K | 352.80K | 207.70K | 372.90K |
Inventory | 1.10M | 1.22M | 1.24M | 1.19M | 744.80K |
Prepaid Expenses | 644.00K | 148.90K | 477.70K | 1.02M | 1.11M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 5.47M | 7.28M | 8.69M | 10.06M | 11.81M |
|
|||||
Total Current Assets | 5.47M | 7.28M | 8.69M | 10.06M | 11.81M |
Net Property, Plant & Equipment | 1.23M | 1.34M | 1.25M | 1.37M | 1.48M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 1.70M | 1.74M | 1.78M | 1.82M | 1.86M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K |
Total Assets | 8.50M | 10.47M | 11.82M | 13.36M | 15.26M |
|
|||||
Total Accounts Payable | 574.60K | 449.00K | 626.20K | 402.60K | 306.50K |
Total Accrued Expenses | 784.40K | 560.60K | 986.80K | 726.00K | 879.40K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 419.70K | 424.30K | 317.80K | 345.50K | 364.20K |
Total Finance Division Other Current Liabilities | 12.30K | 2.00K | 41.00K | 54.60K | 130.40K |
Total Other Current Liabilities | 12.30K | 2.00K | 41.00K | 54.60K | 130.40K |
Total Current Liabilities | 1.79M | 1.44M | 1.97M | 1.53M | 1.68M |
|
|||||
Total Current Liabilities | 1.79M | 1.44M | 1.97M | 1.53M | 1.68M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 529.20K | 633.80K | 644.90K | 725.20K | 802.80K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.32M | 2.07M | 2.62M | 2.25M | 2.48M |
|
|||||
Common Stock & APIC | 119.38M | 119.02M | 118.15M | 118.11M | 118.06M |
Retained Earnings | -113.33M | -110.75M | -109.08M | -107.14M | -105.42M |
Treasury Stock & Other | 128.60K | 128.60K | 128.60K | 128.60K | 128.60K |
Total Common Equity | 6.18M | 8.40M | 9.21M | 11.10M | 12.77M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 6.18M | 8.40M | 9.21M | 11.10M | 12.77M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 6.18M | 8.40M | 9.21M | 11.10M | 12.77M |
|